Patents Assigned to Hananja EHF
  • Methods and systems for the delivery of a therapeutic agent
    Patent number: 9687495
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: June 27, 2017
    Assignees: HANANJA EHF, UNIVERSITY OF ICELAND
    Inventor: Sveinbjorn Gizurarson
  • Methods and compositions for the delivery of a therapeutic agent
    Patent number: 9289432
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: March 22, 2016
    Assignee: HANANJA EHF and UNIVERSITY OF ICELAND
    Inventor: Sveinbjorn Gizurarson
  • Methods and compositions for the delivery of a therapeutic agent
    Patent number: 8809322
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: August 19, 2014
    Assignees: Hananja EHF, University of Iceland
    Inventor: Sveinbjorn Gizurarson
  • BIOLOGICAL ACTIVITY OF PLACENTAL PROTEIN 13
    Publication number: 20140031274
    Abstract: The present invention relates to the biological and pharmacological effects of placental protein 13 (PP-13), an effect that may be used as a treatment and/or prevention of preeclampsia and placental insufficiencies, in pregnant female mammals, especially pregnant women. The invention relates to a method to treat female mammals with the purpose to precondition the uterine arteries and prevent and/or reverse the pathological conditions associated with placental insufficiency such as preeclampsia, HELLP and/or eclampsia.
    Type: Application
    Filed: December 14, 2011
    Publication date: January 30, 2014
    Applicants: UNIVERSITY OF ICELAND, HANANJA EHF
    Inventors: Sveinbjorn Gizurarson, Hamutal Meiri
  • METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT
    Publication number: 20120264745
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Application
    Filed: April 13, 2012
    Publication date: October 18, 2012
    Applicants: University of Iceland, Hananja ehf
    Inventors: Sveinbjorn Gizurarson, James Arp, Raouf Ghaderi, Michael E. Lusty, Gregory G. Plucinski, Mehdi Yazdi
  • Methods and compositions for the delivery of a therapeutic agent
    Patent number: 8217033
    Abstract: The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: July 10, 2012
    Assignees: Hananja EHF, University of Iceland
    Inventor: Sveinbjorn Gizurarson